Vietnam Pharmaceutical Market

1
Vietnam Pharmaceutical Market
2
The report titled Vietnam Pharmaceutical Market
Outlook To 2022 - by Generic and Patented drugs,
by Prescribed Drugs and OTC Drugs and Therapeutic
Drugs (Metabolism and Nutritional Medicine,
Cardiovascular, Central Nervous System, System
Infection, Oncology, Musculoskeletal,
Respiratory) provides a comprehensive analysis of
Vietnam pharmaceutical market overview and size,
growth drivers and restraints. The report also
provides data points on Vietnam Pharmaceutical
market by Generic and Patented drugs, by
Prescribed Drugs and OTC Drugs and Therapeutic
Drugs (Metabolism and Nutritional Medicine,
Cardiovascular, Central Nervous System, System
Infection, Oncology, Musculoskeletal, Respiratory
and Others) along with company profiles of DHG
Pharma, Traphaco, Pymepharco, Ha Tey
Pharmaceutical, Mekophar, Domesco, Imexpharma,
OPC, Sanofi, GSK, AstraZeneca, Novartis, Roche,
Pfizer, MSD and Bayer. The report also covers
government regulations, procedure of how drugs
procured in public hospitals, Comparative
Analysis of Pharmaceutical Companies, Trade
scenario, Analyst Recommendations and future
outlook for Vietnam Pharmaceutical Market.
3
Vietnam Pharmaceutical Market Size and
Overview The pharmaceutical market recorded
growth at a CAGR of during 2012-2017
increasing from USD billion in 2012 to USD
billion in 2017, driven by rise in
self-medicating culture and OTC drug sales.
Foreign entities are not allowed to engage in
distribution activities hence, they typically
conduct marketing activities through
representative offices or local drug
distributors. Heightened regulatory environment
for drug manufacturing has enabled entities which
comply with regulatory standards to remain
competitive.  
4
Market Segmentation By Generic and Patented
Drugs Generic drugs dominated the pharmaceutical
market with higher revenue share of in the in
2017. Most common generic drugs sold in the
market include antibiotics and pain killers.
Patented drugs followed generic drugs segment and
generated revenue share in 2017. Currently all
patented drugs are imported for local
consumption. Widely imported patented drugs
include high-value specialty drugs for oncology
and diabetes management. By Prescribed Drugs and
OTC Drugs Prescribed drugs dominated the
pharmaceutical market with higher revenue share
of in the in 2017. Drugs prescribed by
clinicians mostly consisted of imported and
patented drugs. OTC drugs followed prescribed
drugs segment and generated revenue share in
2017. Sales of OTC drugs have been on an incline
owing to rise in trend of self-medication in
Vietnam. About 88-91 of antibiotics are sold via
OTC channel.
5
By Therapeutic Drugs (Metabolism and Nutritional
Medicine, Cardiovascular, Central Nervous System,
System Infection, Oncology, Musculoskeletal,
Respiratory and Others) Metabolism and
Nutritional Medicine dominated the therapeutic
drugs in pharmaceutical market with highest
revenue share of in the in 2017.
Pharmaceutical market has witnessed high demand
for nutritional and metabolism health supplements
especially for segments including skin care,
anti-aging, eye health and digestive health.
Antibiotic consumption has risen steeply in the
last few years. Recent statistics reveal that
about to of all antibiotics were sold
without prescription in Vietnam. Others include
contraception, gastrointestinal, skin, allergy,
endocrine, analgesic and contributed revenue
share in the therapeutic drugs in the
pharmaceutical market.
6
Future Outlook to Vietnam Pharmaceutical
Market The pharmaceutical market is expected to
record growth at a CAGR of during 2017-2022,
driven by rise in utilization of generic drugs,
especially those manufactured locally. Generic
drug usage will continue to rise in future owing
to rising number of drug manufacturers and
governments push for production and utilization
of locally produced. Prescribed drugs will
dominate the pharmaceutical market but there will
be increase in the OTC medication due to self
medication. Antibiotics, Vitamins and dietary
supplements will continue to attract heavy demand
through OTC channel. Demand for oncology drugs
and system infections medicine is expected to
become almost times the size in 2017 with
revenue contribution of USD million and USD
million in 2022. Respiratory drugs are
anticipated to register highest CAGR of to
reach USD million by 2022.
7
Healthcare Ecosystem Healthcare Scenario Vietnam
Healthcare Market Size Vietnam Healthcare
Segmentation by Revenue (Pharmaceuticals,
Hospital and Clinics, Medical Devices and
Clinical Laboratories) Vietnam Pharmaceutical
Market Overview and Size Vietnam Pharmaceutical
Market Growth drivers Vietnam Pharmaceutical
Market Restraints Vietnam Pharmaceutical Market
by Generic and Patented drugs Vietnam
Pharmaceutical Market by Prescribed Drugs and OTC
Drugs Vietnam Pharmaceutical Market by
Therapeutic Drugs (Metabolism and Nutritional
Medicine, Cardiovascular, Central Nervous System,
System Infection, Oncology, Musculoskeletal,
Respiratory and Others) Government
regulations Procedure of how drugs procured in
public hospitals Comparative Analysis of
Pharmaceutical Companies Trade scenario (Import
and Export) Analyst Recommendations for Vietnam
Pharmaceutical Market Future outlook for Vietnam
Pharmaceutical Market
8
For more information on the research report,
refer to below link https//www.kenresearch.com/h
ealthcare/pharmaceuticals/vietnam-pharmaceutical-m
arket/143605-91.html Related Reports The US
Pharmaceutical Market Outlook to 2016 - Evolving
Opportunities in the Biologics Segment India
Online Healthcare Products Market Outlook to 2020
- Infusion of Online Marketplaces and Healthcare
Awareness to Shape Future Growth Saudi Arabia
Healthcare Market Outlook to 2019 - Rising
Lifestyle Diseases and Government Investment to
Spur Future Growth Contact UsKen ResearchAnkur
Gupta, Head Marketing CommunicationsAnkur_at_kenre
search.com91-9015378249
9
(No Transcript)